polycythemia


Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to polycythemia: polycythemia vera, secondary polycythemia

pol·y·cy·the·mi·a

 (pŏl′ē-sī-thē′mē-ə)
n.
A condition marked by an abnormally large number of red blood cells in the circulatory system.

ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.polycythemia - a disorder characterized by an abnormal increase in the number of red blood cells in the blood
blood disease, blood disorder - a disease or disorder of the blood
Translations

pol·y·cy·the·mi·a

n. policitemia, aumento excesivo de glóbulos rojos;
___ rubra___ vera secundaria, ___ vera;
primary ______ primaria.

polycythemia

n policitemia; — vera policitemia vera
References in periodicals archive ?
PTG-300 is currently in clinical development for the potential treatment of beta-thalassemia, and may also be potentially beneficial in other diseases such as myelodysplastic syndrome, hereditary hemochromatosis, polycythemia vera, siderophilic infections, and liver fibrosis.
Researchers at the National Institutes of Health have cured mice with Chuvash polycythemia, a life-threatening disorder that involves the overproduction of red blood cells.
Kridin and his colleagues measured the prevalence of acute and chronic leukemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and polycythemia vera.
Impact is developing fedratinib for myelofibrosis and polycythemia vera.
The presence of polycythemia may have been responsible for the hypocalcemia as proposed in another case report.
Osumi et al reported secondary polycythemia due to increased EPO production in a patient with leukemic infiltration of the kidneys.
Rats were equally divided into four groups: Control group, curcumin-treated group, EPO-induced polycythemia group, and curcumin + EPO-induced polycythemia group.
Background and Objectives: Polycythemia is a disorder characterized by raised hematocrit (HCT) level of [greater than or equal to] 0.
A diagnosis requires meeting all the following criteria:[sup][1] platelet (PLT) count ≥450 x 10[sup]9/L; megakaryocyte proliferation with large and mature morphology; not meeting the WHO criteria for chronic myeloid leukemia, polycythemia vera, primary myelofibrosis, myelodysplastic syndromes, or other myeloid neoplasm; demonstration of JAK2V617F or other clonal markers or no evidence of reactive thrombocytosis.
In the 2008 World Health Organization classification system, the category of MPNs includes chronic myelogenous leukemia; chronic neutrophilic leukemia; polycythemia vera; primary myelofibrosis; essential thrombocythemia; chronic eosinophilic leukemia; mastocytosis; and MPN, unclassifiable; and the clinical and pathologic findings may overlap with the category of myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement.
Common arguments against DCC include that it causes clinical jaundice, infection, postpartum hemorrhage, polycythemia, and that it interferes with skin-to-skin contact.